LEXX Lexaria Bioscience Corp.
$3.97▼ -1.98%
Healthcare
Other
After hours
$3.84▼ -3.26%
Sep 11, 7:57 PM ET
Volume 195.9K
Avg Volume (10D) 154.9K
Key Metrics & Fundamentals
Market Cap
$8.36M
P/E Ratio
–
Div Yield
–%
52W Range
3.65 - 23.25
% vs 50 MA
-54.36%
% vs 200 MA
-62.76%
RSI-14
33.4
MACD Histogram
-0.9500
Beta (1Y vs SPY)
0.90
Free Cash Flow
-$1.66M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.97M
COGS
$0
Operating Exp
$1.99M
Operating Income
-$1.99M
EBIT
-$1.99M
Pretax Income
-$1.99M
Net Income
-$1.99M
EPS (Diluted)
-1.20
Price & Volume History
Loading chart…
Recent News
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
ACCESS Newswire · Sep 9, 2026 8:15 PM
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
ACCESS Newswire · Sep 8, 2026 12:00 PM
LEXX: Introducing DehydraTECH 3.0
Zacks Small Cap Research · Sep 8, 2026 10:15 AM
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
ACCESS Newswire · Sep 4, 2026 1:20 PM
Lexaria Receives USD$2.6 Million Tax Rebate Payment
ACCESS Newswire · Sep 1, 2026 1:15 PM
DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
ACCESS Newswire · Aug 24, 2026 1:10 PM
Lexaria Enters a Material Transfer Agreement With PegBio
ACCESS Newswire · Aug 13, 2026 1:00 PM
Lexaria Announces Effective Date for Reverse Stock Split
ACCESS Newswire · Jul 30, 2026 3:00 PM
LEXX: Dosing Started for Animal & Human GLP-1 Studies
Zacks Small Cap Research · Jul 17, 2026 3:54 PM
Lexaria Updates Business Development
ACCESS Newswire · Jul 6, 2026 1:10 PM
Financial Overview - Income Statement
Quarterly
Feb 2026
See LEXX's money flow as a full page
Social Sentiment
No Reddit posts found for LEXX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.